About ZMI PHARMA, INC
ZIMHI is a high-dose naloxone intramuscular injection designed for the emergency treatment of opioid overdoses. It is intended for immediate administration in settings where opioids may be present and is not a substitute for emergency medical care.
Emergency treatment of known or suspected opioid overdoseHigh-dose intramuscular naloxone deliveryImmediate administration in opioid-present settings
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ZMI PHARMA, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.